Highlighted transactions

Healthcare

 

Flex Pharma, Inc.

Piper Jaffray served as joint bookrunner on the $86.4 million IPO for Flex Pharma, Inc.

Client Description

Flex Pharma, Inc. is a biotechnology company that is developing innovative and proprietary treatments for nocturnal leg cramps and spasms associated with severe neuromuscular conditions.

Back